Tullis Health Investors

High-margin, high-growth, novel products and services

The Tullis team has completed portfolio company investments in the medical device, healthcare services and technology, specialty pharmaceuticals, and biotechnology sectors

Tullis funds’ investments in people, products, technologies, and services have a significant impact on global health Here’s a snapshot of what our financial support has helped our portfolio companies achieve

Our team invests in medical devices, healthcare services and technology, specialty pharmaceuticals, and biotechnology, and has backed market leaders such as these current and exited portfolio companies

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

SAN DIEGO, Jan 23, 2023 (GLOBE NEWSWIRE) — Exagen Inc (Nasdaq: XGN), a leading provider of autoimmune testing solutions,

electroCore Announces Expected Record 4Q 2022 Revenue of $2.5M; Provides Business Update

ROCKAWAY, N J , Jan 17, 2023 (GLOBE NEWSWIRE) — electroCore, Inc (the “Company”) (Nasdaq: ECOR), a commercial-stage

ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility

CARLSBAD, Calif –(BUSINESS WIRE)– Alphatec Holdings, Inc (Nasdaq: ATEC), a provider of innovative solutions dedicated to